Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 9,210 | 4,346 | 2,766 | 2,398 | 17,570 |
| Cost of Goods | 9,301 | 2,408 | 1,909 | 1,840 | 6,428 |
| Gross Profit | -91 | 1,938 | 857 | 558 | 11,142 |
| Operating Expenses | 99,886 | 12,817 | 14,620 | 20,329 | 15,617 |
| Operating Income | -99,676 | -10,471 | -12,854 | -18,931 | -4,047 |
| Other Income | 3,124 | 2,885 | 1,868 | 1,990 | 2,189 |
| Pre-tax Income | -96,552 | -7,586 | -10,986 | -16,941 | -1,858 |
| Net Income Continuous | -96,552 | -7,586 | -10,986 | -16,941 | -1,491 |
| Net Income | $-96,552 | $-7,586 | $-10,986 | $-16,941 | $-1,491 |
| EPS Basic Total Ops | -1.21 | -0.11 | -0.15 | -0.24 | -0.02 |
| EPS Basic Continuous Ops | -1.21 | -0.11 | -0.15 | -0.24 | -0.01 |
| EPS Diluted Total Ops | -1.21 | -0.11 | -0.15 | -0.24 | -0.02 |
| EPS Diluted Continuous Ops | -1.21 | -0.11 | -0.15 | -0.24 | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.11 | -0.15 | N/A | N/A |
| EBITDA(a) | $-99,533 | $-10,292 | $-12,612 | $-18,688 | $-3,819 |